FindTrial
Sign In

Clinical research on the treatment of chronic atrophic gastritis with Guben Fuwei Decoction

Clinical research on the treatment of chronic atrophic gastritis with Guben Fuwei Decoction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001366
Enrollment
Unknown
Registered
2025-07-09
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic atrophic gastritis

Interventions

Control group:Selenium yeast tablets Ribamate tablets
Treatment group:Guben Fuwei Decoction

Sponsors

Shanghai Putuo Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1)After gastroscopy and biopsy of the gastric mucosa the pathology was confirmed to be atrophic gastritis. (2) Age: 18 to 70 years old. (3) Gender is not limited. (4) Those who voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those with concurrent peptic ulcers and gastroesophageal reflux disease who need to take acid-suppressing drugs for a long time. (2) Patients with a history of upper gastrointestinal surgery \ n (3) Pregnant women or women in the preconception period. (4) Those with severe dysfunction of vital organs such as the heart lungs brain liver and kidneys. (5) Patients with malignant tumors.

Design outcomes

Primary

MeasureTime frame
Gastroscopy and pathological biopsy;Gastrin;Pepsinogen;—

Secondary

MeasureTime frame
Eradication rate of Helicobacter pylori;—

Countries

China

Contacts

Public ContactWang Xuewei

Shanghai Putuo Central Hospital

18801809886@163.com18801809886

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026